 "Covid-19: No human challenge experiments in India yet, says Harsh Vardhan")
India is not planning to venture into human challenge experiments for the coronavirus vaccine until the method is proven to have an established benefit according to global experience, Health Minister Harsh Vardhan said.
Human challenge trials, which have raised ethical concerns, involve exposing the participants to the virus on purpose to study the effectiveness of the vaccine. “When conducted, human challenge studies should be undertaken with abundant forethought, caution and oversight. The value of the information to be gained should clearly justify the risks to human subjects,” Vardhan added.
He said that India has robust processes in place to ensure the vaccines that successfully complete the clinical trials are safe and effective against the novel coronavirus. According to reports, the UK is planning to host such a trial on a group of volunteers in January next year.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%